PUBLICATION AND EVENTS

Investor presentations

2024

EUROAPI suspends its 2024 financial guidance

MARCH 14, 2024

EUROAPI management held a live audio webcast with the financial community.
The presentation was followed by a Q&A session.

Access all information

2023

2023 Full year results

FEBRUARY 29, 2024

2023 full year results were presented by management during a live audio webcast with the financial community.

Access all information

EUROAPI updates its 2023 financial guidance

OCTOBER 9, 2023

2023 financial guidance update was presented by management during a live audio webcast with the financial community.
The presentation was followed by a Q&A session.

Access all information

Investor Deck Q4 2023
2023 Half year results

AUGUST 1, 2023

2023 half year results were presented by management during a live audio webcast with the financial community.

Access all information

2022

2022 Full year results

March 8, 2023

2022 full year results were presented by management during a live audio webcast with the financial community.

Access information

EUROAPI updates its 2022 financial guidance

December 7, 2022

2022 financial guidance update was presented by management during a live audio webcast with the financial community.
The presentation was followed by a Q&A session.

Access the webcast

H1-21 and FY21 financial information for modelling purposes

July 1, 2022

EUROAPI has made available some financial information related to half year 2021 and full year 2021, notably its consolidated income statement and some restated adjusted performance measures including certain reclassifications for comparability purposes with 2022.

Access information

EUROAPI Capital Markets Day

April 1, 2022

EUROAPI held its first Capital Markets Day outlining its strategy with the presence of its entire Executive Committee as a new listed company independent from Sanofi.

Access all information